Rifabutin triple therapy increased H pylori eradication vs. amoxicillin + omeprazole in treatment-naive patients
- PMID: 32926814
- DOI: 10.7326/ACPJ202009150-033
Rifabutin triple therapy increased H pylori eradication vs. amoxicillin + omeprazole in treatment-naive patients
Abstract
Graham DY, Canaan Y, Maher J, et al. Rifabutin-based triple therapy (RHB-105) for Helicobacter pylori eradication: a double-blind, randomized, controlled trial. Ann Intern Med. 2020;172:795-802. 32365359.
Comment on
-
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.Ann Intern Med. 2020 Jun 16;172(12):795-802. doi: 10.7326/M19-3734. Epub 2020 May 5. Ann Intern Med. 2020. PMID: 32365359 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical